Micro Emerging Active

Il titolo Travere Therapeutics sale con l'approvazione della FDA

New narrative with limited coverage — still forming.

Punteggio
0,5
Velocità
▲ 1,0
Articoli
2
Fonti
1

Sentiment Timeline

Event Timeline

Apr 26, 2026
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now? Bullish
Apr 21, 2026
Travere Therapeutics (TVTX) Climbs 40.8% on Filspari Approval Neutral

Articoli Correlati

Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?

Yahoo Finance · Apr 26, 2026
Mixed

Cronologia

Ultimo aggiornamentoApr 21, 2026